Please login to the form below

Envision Pharma Group ranked in Top 10 of the fastest-growing UK companies in pharma

Envision has achieved sixth position in the annual ranking of the UK’s Top 50 fastest-growing privately owned pharma businesses.

This marks the second successive year Envision has reached financial services firm Alantra’s Pharma Fast 50 list. Based on revenue growth, it recognizes the key British companies that are driving the healthcare sector forward.

Envision CEO David Thompson said, “We are very proud to be named once again in the Pharma Fast 50 list. To move from 19th place in 2019 to sixth in the rankings this year, speaks to all the hard work and dedication our superb team has put in as we continue to expand our technology-enabled scientific services for clients.”

Alantra Director and report author Tom Cowap comments in the publication, “These are dynamic and innovative businesses that continue to deliver remarkable growth and we are proud to highlight their success.”

Aside from additional recent industry awards that have been based on client campaigns and innovation within the sector, Envision as a business has previously enjoyed year-on-year accolades:

2019 – Positioned 19th in Alantra Pharma Fast 50, fastest-growing privately owned pharma business

2018 – Awarded at Super Sussex Growth event that highlighted top-performing, job-generating businesses

2017 – Named Best in Business for sustained sales growth as a mid-market company among the Top 20 fastest-growing businesses

To view the 2020 Pharma Fast 50 report, click here.


About Envision Pharma Group

Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision®) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.

Envision has 13 offices: five in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London and Wilmslow; one in Serbia – Subotica; one in Hungary – Szeged; four in the United States – Fairfield and Glastonbury, CT, Philadelphia, PA, Warren, NJ; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs around 740 team members, including over 250 highly qualified and experienced in-house medical writers, and 190 technology solutions team members who provide software development and customer support. To find out more, visit www.envisionpharmagroup.com.

For further information, please contact:
Marsha Caplin
Global Head of Marketing
Envision Pharma Group
Email: marsha.caplin@envisionpharmagroup.com
Tel: +44 (0)7557 083549

26th March 2020

Share

Tags

Company Details

Envision Pharma Group

01403 322 000

Contact Website

Address:
Envision House
5 North Street
Horsham
West Sussex
RH12 1XQ
England

Latest content on this profile

Envision Pharma Group scoops two Silvers at the PM Society Digital Awards 2020
The PM Society Digital Awards 2020 saw Envision pick up two Silver awards for Congress, Meetings & Events and for Innovation – Creativity as a result of its “See through diabetes” work in collaboration with Mundipharma.
Envision Pharma Group
90TEN acquired by Envision Pharma Group
90TEN’s award-winning behavioral science-led communications group will help deliver a deeper and more diversified offering to Envision’s clients, while bringing significant geographical expansion opportunities for the London-based team.
Envision Pharma Group
Envision Pharma Group ranked in Top 10 of the fastest-growing UK companies in pharma
Envision has achieved sixth position in the annual ranking of the UK’s Top 50 fastest-growing privately owned pharma businesses.
Envision Pharma Group
The Value of Medical Affairs
Defining Strategic Metrics to Demonstrate Impact
Envision Pharma Group
Showreel

Envision Pharma Group